Anthropic has built something it says is too dangerous to let out into the world. The company calls it Mythos — an AI model so powerful at finding ... well, we don't know exactly what it finds, because Anthropic won't say. What we do know is that the same company now reportedly has its sights set on an initial public offering. The contradiction writes itself.

Let's start with what we can confirm. Anthropic — the AI safety company founded by former OpenAI employees — claims to have developed a new model, referred to internally as Mythos, that poses risks significant enough to warrant keeping it from the public. The company has framed this as a responsible, safety-first decision. A model that could be misused in ways the company cannot fully predict or control should not be deployed. That is the public-facing message.

But the financial press has been circulating a different story for months: Anthropic is weighing an IPO, possibly as soon as 2025. The company has raised billions from investors including Google, Salesforce, and others. An IPO would be the natural next step for a high-growth AI startup that needs capital to compete with OpenAI and Google DeepMind. The problem is that an IPO and a genuinely dangerous, unreleasable product do not fit together neatly.

The safety argument as a product position

Anthropic's founding ethos is built on the idea that AI safety needs to be taken seriously from day one. That stance has been a powerful differentiator in a market where OpenAI has been criticized for moving fast and breaking things. By calling Mythos too dangerous, Anthropic reinforces its brand as the responsible AI company. It signals to regulators, academia, and the public that Anthropic takes safety more seriously than its competitors.

But there is another way to read this: If the model is genuinely too dangerous to release, why build it in the first place? And if it is too dangerous to release, what does that say about the company's other models that are already being sold to enterprise customers? The implied answer is that Anthropic has a spectrum of risk: some models are safe enough to sell, and Mythos sits on the wrong side of that line. That distinction is plausible, but it demands a level of transparency Anthropic has not provided.

The IPO clock is ticking

IPO preparations are not a sign of a company that wants to stay small and cautious. They are a sign of a company that wants to grow fast, satisfy investors, and eventually deliver returns. Venture capital firms that have poured money into Anthropic do not expect infinite patience. They expect liquidity events. An IPO would be the biggest liquidity event in the AI industry since ... well, maybe ever, except for OpenAI's rumored public offering.

The timing matters. By floating the idea of a dangerous unreleasable model while simultaneously preparing to go public, Anthropic is trying to have it both ways. It wants the regulatory goodwill of a safety-first company while also feeding the growth narrative that investors demand. Those two images are in tension.

What does 'too dangerous' actually mean?

Anthropic has not published benchmarks or detailed evaluations that would allow independent researchers to verify the danger level of Mythos. The claim rests on the company's own internal assessments. That is a problem. Without third-party validation, calling a model "too dangerous" becomes a non-falsifiable statement — a way to control the narrative without releasing evidence.

It could be true. An AI capable of autonomously finding novel cyber vulnerabilities, designing bioweapons, or manipulating human decision-making at scale would indeed be dangerous. But Anthropic has not said which specific capabilities crossed the line. The vagueness invites skepticism. Critics will ask: Is the model actually dangerous, or is the label a convenient way to build hype while avoiding the responsibility of releasing a product that might fail commercially?

The regulatory angle

Governments around the world are scrambling to write AI laws. The European Union's AI Act is already in effect. The United States has issued executive orders on AI safety. Calling a model too dangerous positions Anthropic as a cooperative partner for regulators. It says: we are self-policing, you can trust us. That is a strategic advantage when lawmakers are deciding which companies to consult and which to investigate.

But it also creates a potential trap. If regulators take Anthropic at its word and demand stricter controls across the industry, the company could find itself boxed in. Disclosing too much about Mythos could trigger mandatory reporting requirements that slow down its entire product pipeline. The IPO could then be delayed or valued lower. The safest path might be to keep Mythos vague and let the story fade into the background as IPO preparations accelerate.

What comes next

The most likely outcome is that Anthropic will either release a limited version of Mythos with heavy safety guardrails, or shelve it quietly while continuing to sell its less dangerous models to enterprise clients. The company will point to its internal review process as proof of responsibility, and investors will nod along as long as revenue growth meets targets.

If Anthropic does go public, the prospectus will be fascinating. It will have to disclose risk factors — including the possibility that future models could be deemed too dangerous to commercialize. That could spook investors or, paradoxically, reassure them that the company takes safety seriously enough to survive regulatory scrutiny.

The bottom line

Anthropic's handling of Mythos tells us more about the business of AI than about the technology itself. Safety is a marketable attribute. Calling a product too dangerous is a form of marketing — one that works best when the product remains behind closed doors. An IPO forces those doors open, whether the company is ready or not.

SysCall News will continue to track Anthropic's IPO timeline and any concrete disclosures about Mythos. Until the company provides third-party evaluations or specific capability benchmarks, the safest take remains the most cynical one: the danger narrative serves a purpose beyond safety. And that purpose may have a lot to do with the price of shares.